The suitability of a poly(sodium methacrylate, methyl methacrylate) (NaPMM), a novel mucoadhesive material, to prepare fastdissolving microparticles containing nifedipine (NIF) in the range of 25–75% w/w was verified. Microparticles made of a low-viscosity hydroxypropylmethylcellulose (HPMC), were also prepared to compare the NIF release profile and bioadhesive properties. The release test was carried out in oversaturation conditions. The physical state of microparticles was also investigated. The formulation stability was evaluated over a 3-month period in long-term and accelerated conditions. The presence of amorphous NIF within freshly prepared microparticles was attributed to interactions between the drug and both polymers. NaPMM conf...
The main objective of the study was to enhance the dissolution of nifedipine, a poorly water soluble...
The purpose of the present investigation was to design and evaluate sustained release tablets of a p...
Nifedipine is an antihypertensive BCS class II drug which has poor bioavailability when given orally...
The aim of the present work was to prepare and evaluate sublingual fast dissolving niosomal films co...
Nifedipine (NIF) is a 1,4-dihydropyridine-based calcium channel blocker with poor solubility, whose ...
Abstract. We performed the quantitative physical identification of Nifedipine microsphere which show...
ABSTRACT: Fast disintegrating tablets of nifedipine prepared by superdisintegrant addition and subli...
The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublin...
In this study, nifedipine (NFP)-loaded polymeric nanocapsules were prepared and characterised with a...
<p>In this study, nifedipine (NFP)-loaded polymeric nanocapsules were prepared and characterised wit...
Nifedipine is a calcium channel blocker widely used for the treatment of blood pressure related dise...
We investigated the effect of polymer composition on nifedipine (NIF) dissolution through molecular-...
We have studied the feasibility of preparing fast-dissolving mucoadhesive microparticulate delivery ...
Objectives: The purpose of this research work was to formulate and systemically evaluate in vitro pe...
Sustained release oral delivery systems are designed to achieve therapeutically effective concentrat...
The main objective of the study was to enhance the dissolution of nifedipine, a poorly water soluble...
The purpose of the present investigation was to design and evaluate sustained release tablets of a p...
Nifedipine is an antihypertensive BCS class II drug which has poor bioavailability when given orally...
The aim of the present work was to prepare and evaluate sublingual fast dissolving niosomal films co...
Nifedipine (NIF) is a 1,4-dihydropyridine-based calcium channel blocker with poor solubility, whose ...
Abstract. We performed the quantitative physical identification of Nifedipine microsphere which show...
ABSTRACT: Fast disintegrating tablets of nifedipine prepared by superdisintegrant addition and subli...
The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublin...
In this study, nifedipine (NFP)-loaded polymeric nanocapsules were prepared and characterised with a...
<p>In this study, nifedipine (NFP)-loaded polymeric nanocapsules were prepared and characterised wit...
Nifedipine is a calcium channel blocker widely used for the treatment of blood pressure related dise...
We investigated the effect of polymer composition on nifedipine (NIF) dissolution through molecular-...
We have studied the feasibility of preparing fast-dissolving mucoadhesive microparticulate delivery ...
Objectives: The purpose of this research work was to formulate and systemically evaluate in vitro pe...
Sustained release oral delivery systems are designed to achieve therapeutically effective concentrat...
The main objective of the study was to enhance the dissolution of nifedipine, a poorly water soluble...
The purpose of the present investigation was to design and evaluate sustained release tablets of a p...
Nifedipine is an antihypertensive BCS class II drug which has poor bioavailability when given orally...